Natural and synthetic homoisoflavonoids and related compounds for the treatment of macular degeneration
The inhibition of angiogenesis is a drug target with widespread application. Macular conditions affect around 1.5 million people in the UK, with most of them suffering from age-related macular degeneration. AMD is the biggest cause of sight loss in the UK, affecting about 600 000 people. Wet age-rel...
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Published: |
Georg Thieme Verlag KG
2022
|
| Subjects: |